Metabolic impairment of brain metabolism in patients with Lewy body dementia

European Journal of Neurology

Volumn 10, Issue 5, 2003, Pages 573-575

  Mirzaei, S ^a,c   Rodrigues, M ^a   Koehn, H ^a   Knoll, P ^a   Bruecke, Th ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Wilhelminenspital ^*  (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

Author keywords

18F FDG PET; Dementia; Lewy body disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; DIAGNOSTIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFUSE LEWY BODY DISEASE; GLUCOSE METABOLISM; HUMAN; LEWY BODY; MALE; METABOLIC DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; SENILE DEMENTIA; SENSORIMOTOR CORTEX; BRAIN; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; METABOLISM; METHODOLOGY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEWY BODY DISEASE; MALE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0142023987     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00650.x     Document Type: Article

References (23)

1. Akatsu H, Takahashi M, Matsukawa N et al. (2002). Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. Neurol Sci 196:63-69.
2. Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AAF (1996). Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 47: 462-466.
3. Byne EJ, Lennox G, Godwin-Austen R (1989). Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiat 52:709-717.
4. Costa DC, Pilowsky LS, Ell PJ (1999). Nuclear medicine in neurology and psychiatry. Lancet 354:1107-1111.
5. Donnemiller E, Heilmann J, Wenning GK et al. (1997). Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 24:320-325.
6. Foerstl H, Burns A, Luther P, Cairns N, Levy R (1993). The Lewy body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 162:385-392.
7. Gibb WR, Luthert PJ, Janota I, Lantos PL (1989). Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiat 52:185-192.
8. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P (1997). Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiat 62:243-252.
9. Hansen LA, Noville RL (1992). Lewy body disease. Curr Opin Neurol Neurosurg 5:889-894.
10. Hansen L, Salmon D, Galasko D et al. (1990). The Lewy body variant of Alzheimer's disease: a pathological and clinical entity. Neurology 40:1-8.
11. Hishikawa N, Hashizume Y, Yoshida M, Sobue G. (2003). Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol (Berl) 105:341-350.
12. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984). Diffuse type of Lewy disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropharmacol 3:185-192.
13. Lebert F, Soulliez L, Pasquier F (1996). Tacrine and symptomatic treatment in Lewy body dementia. In: Perry R, McKeith I, Perry E, eds. Dementia with Lewy bodies. Clinical, Pathological and Treatment Issues. Cambridge University Press, Cambridge, pp. 439-448.
14. Levine DN, Lee JM, Fischer CM (1993). The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology 43:305-313.
15. Lewy FH (1912). Paralysis agitans. In: Lewandowsky M, ed. Pathologische Anatomie. Handbuch der Neurologie. Springer Verlag, Berlin, pp. 920-933.
16. Lopez OL, Hamilton RL, Becker JT, Wisniewski S, Kaufer DI, DeKosky ST (2000). Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies. Neurology 54:1780-1787.
17. McKeith IG, Galasko D, Kosaka K et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113-1124.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
19. Mirzaei S, Knoll P, Köhn H (2000). Comparison of different methods for attenuation correction in brain PET. Nuklearmedizin 39:N95.
20. Neary D, Snowden JS, Shields RA, Burjan AWI, Northen B (1987). Single photon emission tomography using 99mTc-HMPAO in the investigation of dementia. J Neurol Neurosurg Psychiat 50:1101-1109.
21. Ransmayr G, Wenning GK, Seppi K, Jellinger K, Poewe W (2000). Demenz mit Lewy-Körperchen. Nervenarzt 71:929-935.
22. Santa Cruz KS, Tasaki CS, Kim RC, Cotman CW (2002). Brainstem and cortical Lewy bodies in patients presenting clinically with Alzheimer's disease. J Alzheimers Dis 4: 11-17.
23. Waldemar G, Bruhn P, Kristensen M, Johnsen A, Paulson OB, Lassen NA (1994). Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a 99mTc-d,1-HMPAO SPECT study. J Neurol Neurosurg Psychiat 57:285-295.